Literature DB >> 8908388

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

S Savage1, R O Estacio, B Jeffers, R W Schrier.   

Abstract

OBJECTIVE: The relationship between urinary albumin excretion (UAE) and diabetic complications in NIDDM has not been studied in a large American population. The demonstrated relationship between increased UAE and the development of retinopathy, nephropathy, and neuropathy in IDDM makes this an important issue to also be studied in NIDDM patients. RESEARCH DESIGN AND METHODS: A large population study of 947 NIDDM patients living predominantly in a metropolitan area was undertaken. Three categories of UAE, namely, normal albuminuria (< 20 micrograms/min), microalbuminuria (20-200 micrograms/min), and overt albuminuria (> 200 micrograms/min) were compared with 1) retinopathy as assessed by stereoscopic fundus photographs; 2) cardiovascular disease as assessed by a history of cardiac disease or stroke; ischemic changes on exercise treadmill testing; Q wave myocardial infarction; Estes, Sokolow, or Cornell criteria for left ventricular hypertrophy; positive Rose questionnaire for angina; and an abnormal Doppler exam for peripheral vascular disease; and 3) neuropathy as assessed by neurological symptom and disability scores, autonomic function testing, and quantitative sensory exams involving thermal and vibratory sensation. Selected patient characteristics were then evaluated to determine their effects on the presence of diabetic complications using univariate analyses. Multiple logistic regression analyses were then performed to determine the independent effect of UAE on these diabetic complications.
RESULTS: chi 2 analyses revealed that UAE was significantly associated with the presence of retinopathy (P < 0.001), neuropathy (P < 0.001), and cardiovascular disease (P < 0.001). In the multiple logistic regression analyses, UAE had strong independent associations with retinopathy, neuropathy, and cardiovascular disease.
CONCLUSIONS: Thus, increasing UAE in this large NIDDM population in the U.S. was associated with an increased prevalence of diabetic retinopathy, neuropathy, and cardiovascular disease. This suggests that UAE may be more than an indicator of renal disease in NIDDM patients and, in fact, may reflect a state of generalized vascular damage occurring throughout the body. Prospective studies in NIDDM patients are needed to determine the predictive effect of UAE and the effect of decreasing UAE on future diabetic micro- and macrovascular complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8908388     DOI: 10.2337/diacare.19.11.1243

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  35 in total

1.  Measures of cardiovascular autonomic nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects.

Authors:  J Gerritsen; B J TenVoorde; J M Dekker; R Kingma; P J Kostense; L M Bouter; R M Heethaar
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

2.  Link between retinopathy and nephropathy caused by complications of diabetes mellitus type 2.

Authors:  Pavel Kotlarsky; Arkady Bolotin; Karina Dorfman; Boris Knyazer; Tova Lifshitz; Jaime Levy
Journal:  Int Ophthalmol       Date:  2014-11-13       Impact factor: 2.031

Review 3.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

Review 4.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

Authors:  G F M Strippoli; C Bonifati; M Craig; S D Navaneethan; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Authors:  Faramarz Ismail-Beigi; Timothy Craven; Mary Ann Banerji; Jan Basile; Jorge Calles; Robert M Cohen; Robert Cuddihy; William C Cushman; Saul Genuth; Richard H Grimm; Bruce P Hamilton; Byron Hoogwerf; Diane Karl; Lois Katz; Armand Krikorian; Patrick O'Connor; Rodica Pop-Busui; Ulrich Schubart; Debra Simmons; Harris Taylor; Abraham Thomas; Daniel Weiss; Irene Hramiak
Journal:  Lancet       Date:  2010-06-30       Impact factor: 79.321

Review 6.  Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Authors:  Anna Grisold; Brian C Callaghan; Eva L Feldman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-04       Impact factor: 3.243

7.  Glycaemia Status, Lipid Profile and Renal Parameters in Progressive Diabetic Neuropathy.

Authors:  Debahuti Mohapatra; Komaladevi Sampath Damodar
Journal:  J Clin Diagn Res       Date:  2016-09-01

8.  Mayombian ethnic, vegetables low intake, insulin treatment, diabetic nephropathy and severe diabetic retinopathy are determinants of blindness in diabetic Africans.

Authors:  Mvitu Muaka Moise; Longo-Mbenza Benjamin; Cibanda Yokobo Enoch; Longo Phemba Igor
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

9.  Autonomic neuropathy in asymptomatic subjects with non-insulin-dependent diabetes mellitus and microalbuminuria.

Authors:  M K Rutter; J M McComb; S Brady; S M Marshall
Journal:  Clin Auton Res       Date:  1998-10       Impact factor: 4.435

10.  The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in isfahan, iran.

Authors:  Massoud Amini; Hassan Safaei; Ashraf Aminorroaya
Journal:  Rev Diabet Stud       Date:  2008-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.